Bradley Robinson is President and CEO at Predictive Technology Group. Predictive is a Life Sciences holding company that develops and commercializes discoveries and technologies involved in novel molecular diagnostics, regenerative tissues (HCT/Ps) and pharmaceutical therapeutic products. Predictive, through its subsidiaries, has developed and/or acquired a number of technologies that open a window into the origin of human disease and the role that genes and their related proteins play in the disease’s onset and progression.
Brad brings operational, transactional, business development and financing experience to Predictive.
Brad studied accounting at the University of Utah and earned an MBA/MIM from the Graduate School of International Management (Thunderbird).